Akari Therapeutics PLC banner

Akari Therapeutics PLC
F:CLA

Watchlist Manager
Akari Therapeutics PLC Logo
Akari Therapeutics PLC
F:CLA
Watchlist
Price: 0.0556 EUR
Market Cap: €198.7m

Dividends

Akari Therapeutics PLC
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Akari Therapeutics PLC

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Akari Therapeutics PLC

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

CLA Price
Akari Therapeutics PLC

Annual Price Range
0.0556
52w Low
0.0556
52w High
41.2
Price Metrics
Average Annual Return -50.69%
Standard Deviation of Annual Returns 28.8%
Max Drawdown -100%
Shares Statistics
Market Capitalization 18.8m EUR
Shares Outstanding 3 573 970 000
Percentage of Shares Shorted
N/A

CLA Return Decomposition
Main factors of price return

Stock Splits

CLA's latest stock split occurred on Mar 31, 2026

The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.

Before the split, CLA traded at 2.44 per share. Afterward, the share price was about 0.0556.

The adjusted shares began trading on Mar 31, 2026. This was stock split number 2 in CLA's history, following the previous one in Aug 17, 2023.

Pre-Split Price
2.44 2.44
Post-Split Price
0.0556
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett